Company: Dr. Reddy's Laboratories Ltd. Category: Company News

The Cubicin for Injection (daptomycin for injection) brand and generic had US sales of ~$640.8mn MAT for the most recent twelve months ending in March 2019, according to IQVIA Health.
May 15, 2019, 12:40 p.m.

As per IQVIA Health data, the AndroGel (testosterone gel) brand and generic had US sales of ~$815.6mn MAT for the most recent twelve months ending in February 2019.
May 6, 2019, 2:52 p.m.

According to information posted on the US Food and Drug Administration(USFDA), the company initiated a voluntary recall of Divalproex 100-count and 500-count bottles, totaling 33,958 bottles on April
April 26, 2019, 2:12 p.m.

The company has received approval for the product Clopidogrel in China.
April 25, 2019, 3:21 p.m.

Sources said the company got approval earlier this month for generic Clopidogrel, which is used primarily to prevent blood clotting and acts against cardiovascular problems
April 23, 2019, 9:22 p.m.

Shares of Lupin and Sun Pharma, which rose 4% and 3%, respectively, were leading the indexs gain.
April 23, 2019, 2:22 p.m.

The company said it has entered into a definitive agreement to acquire yet to be marketed portfolio of ANDAs, including more than 30 generic injectable products
April 13, 2019, 9:15 p.m.

Dr Reddy’s Laboratories Ltd, through its wholly owned subsidiary Promius Pharma, LLC, has sold its rights for Sernivo (betamethasone dipropionate).
April 2, 2019, 11:56 a.m.

Dr Reddy's Tadalafil Tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.
March 27, 2019, 12:03 p.m.

The audit of Research and Development facility of Aurigene Discovery Technologies Limited, a wholly owned subsidiary, situated at Hyderabad by the USFDA, has been completed on March 21, 2019.
March 25, 2019, 8:49 a.m.